Latest News for: pfizer inc.

Edit

High Potency API Contract Manufacturing Market Set to Reaching USD 16 Billion by 2032

Pharmiweb 24 Apr 2025
Surge in Cancer Incidences Fuels HPAPI Market Growth ... Piramal Pharma Solutions Lonza Catalent, Inc. VxP Pharma, Inc. Pfizer CentreOne Gentec Pharmaceutical Group AbbVie Aurigene Pharmaceutical Services Ltd. CordenPharma International Curia Global, Inc ... .
Edit

Recent GLP-1-Industry Developments Highlight the Promise of Lexaria Bioscience’s Technology

ACCESSWIRE 23 Apr 2025
(NASDAQ.LEXX)(NASDAQ.LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, provides the following glucagon-like peptide-1 ("GLP-1") strategic update following important industry developments reported both by Pfizer® Inc.
Edit

Prostate Cancer Clinical Trials Analysis 2025: EMA, PDMA, FDA Approvals, Clinical Trials, Therapies, Medication, NDA ...

GetNews 22 Apr 2025
Key prostate cancer companies such as Curium, Merck, Telix Pharmaceuticals, Exelixis, AstraZeneca, AB Science, Lantheus, Pfizer, Jiangsu Hengrui Pharmaceuticals, Modra ... LNTH), Pfizer Inc.
Edit

Global Branded Generics Market Poised for Robust Growth, Estimated to Reach USD 860.5 Billion by 2035 | Future Market Insights, Inc.

Pharmiweb 22 Apr 2025
Canadian pharmaceutical company Apotex Inc. announced the successful acquisition of Searchlight Pharma Inc., a leading player in the Canadian pharmaceutical market ... (Viatris Inc.) Novartis AG Teva Pharmaceuticals Pfizer Inc ... AbbVie Inc.
Edit

Desmoid Tumors Treatment Market Size in 7MM is expected to grow at a decent CAGR ...

GetNews 22 Apr 2025
The leading Desmoid Tumors Companies such as SpringWorks Therapeutics, Immunome/Ayala Pharmaceuticals, Iterion Therapeutics, Eisai and PRISM BioLab, MedPacto, Inc., Pfizer, Novartis, SpringWorks ...
Edit

Global Glaucoma Therapeutics Market Set to Reach USD 10.2 Million by 2032, Driven by Aging Population and Technological Advancements in Treatment | FMI

Pharmiweb 22 Apr 2025
Glaucoma Therapeutics Market ... Keep Up with Market Trends ... Regional Outlook ... Allergan Merck & Co., Inc. Akorn, Inc ... Teva Pharmaceuticals Alcon Pfizer Santen Nanodropper, Inc. Novai NeuBase Therapeutics Ocular Therapeutix Aerie Pharmaceuticals Inc ... .
Edit

Global Dysmenorrhea Treatment Market Set to Surpass USD 14,185.1 Million by 2035 amid Growing Awareness and Innovation in Women’s Health | FMI

Pharmiweb 22 Apr 2025
Dysmenorrhea Treatment Market ... Dysmenorrhea, or painful menstruation, has increasingly become a focal point of women’s health discussions ... Stay Updated with Market Movements ... AbbVie Inc ... Hoffmann-La Roche Ltd Novartis AG Amgen Inc. Pfizer Inc. Biogen Inc ... .
Edit

Pfizer Political Action Committee (PAC) Report January 2023 - December 2024 (Pfizer Inc)

Public Technologies 21 Apr 2025
We are pleased to share our 2024 election cycle political contributions report, which includes a list of candidates and political committees supported either by Pfizer Inc ... In the 2024 cycle, the Pfizer PAC and Pfizer Inc ... PFIZER PAC ... Pfizer Inc.
Edit

Beyond Vax Dangers: Other Big Pharma Products Mired in Lawsuits for Fraud, Cancer, and Other ...

UK Column 20 Apr 2025
Pfizer’s Frauds ... Of course, Pfizer shot back. Bloomberg Law News quoted Pfizer spokesman as saying ... We mustn’t forget that Pfizer Inc ... Pfizer and Beyond ... According to Bloomberg Law News, as of 4 April 2025, the drug companies GSK Plc and Pfizer Inc...
Edit

Increasing Need to Eliminate Various Diseases Fuels Demand for Paediatric Vaccine Market to reach a valuation of USD 184,706.7 Million by 2033

Pharmiweb 17 Apr 2025
In May 2023, vaccines from companies GSK plc and Pfizer Inc ... Additionally, Meissa Vaccines Inc ... On 31 August 2022, Pfizer Inc ... Inc Pfizer Inc. Sanofi SA Panacea Biotec Zydus Cadila Emergent BioSolutions Inc Serum Institute of India Pvt.
×